James Investment Research Inc. lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,967 shares of the company's stock after selling 4,603 shares during the quarter. Procter & Gamble comprises 1.8% of James Investment Research Inc.'s holdings, making the stock its 9th largest holding. James Investment Research Inc.'s holdings in Procter & Gamble were worth $14,310,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently added to or reduced their stakes in PG. Navigoe LLC acquired a new stake in shares of Procter & Gamble during the fourth quarter worth about $31,000. Capital A Wealth Management LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $31,000. Hoey Investments Inc. increased its position in shares of Procter & Gamble by 321.7% in the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after buying an additional 148 shares in the last quarter. 10Elms LLP purchased a new stake in shares of Procter & Gamble during the fourth quarter worth approximately $34,000. Finally, Sunbeam Capital Management LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth approximately $34,000. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
Shares of PG traded up $1.95 during mid-day trading on Thursday, hitting $155.68. The company's stock had a trading volume of 8,274,248 shares, compared to its average volume of 7,647,824. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47. The firm has a 50-day simple moving average of $161.43 and a 200 day simple moving average of $164.61. The firm has a market capitalization of $364.99 billion, a P/E ratio of 24.71, a P/E/G ratio of 4.35 and a beta of 0.40. Procter & Gamble Company has a 1-year low of $151.90 and a 1-year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The business had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The company's quarterly revenue was down 2.1% compared to the same quarter last year. During the same period last year, the firm earned $1.52 EPS. Analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a $1.0568 dividend. The ex-dividend date is Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.72%. Procter & Gamble's dividend payout ratio is currently 67.14%.
Analysts Set New Price Targets
A number of equities analysts have weighed in on PG shares. Barclays boosted their price objective on Procter & Gamble from $160.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday. JPMorgan Chase & Co. decreased their price target on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Redburn Atlantic downgraded Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective on the stock. in a report on Thursday, May 1st. Royal Bank Of Canada upgraded Procter & Gamble from a "sector perform" rating to an "outperform" rating and upped their price target for the stock from $164.00 to $177.00 in a report on Friday, April 25th. Finally, Citigroup cut their price target on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $176.80.
Read Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the transaction, the insider directly owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the transaction, the chief executive officer directly owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.